Aegerion Investor Says CEO Job Offer 'Taints' $43M Deal
An investor in Aegerion Pharmaceuticals Inc. launched a lawsuit in Delaware Chancery Court on Monday seeking to halt the company's proposed $43.4 million merger with QLT Inc., alleging that Aegerion CEO...To view the full article, register now.
Already a subscriber? Click here to view full article